Abstract
Since the description of postinfection irritable bowel syndrome (IBS), a role for gut microbes in the pathogenesis of IBS has been proposed. Molecular microbiological tools have now been applied to IBS, though data are largely derived from fecal samples with attendant limitations. Metagenomics, metabolomics, and other ‘omics facilitate a comprehensive picture of the microbiome and its metabolic activity. Has a microbial signature characteristic of IBS been identified? The answer is no; this should not be a surprise given the heterogeneity of the phenotype and each individual’s microbiome profile.
Original language | English (US) |
---|---|
Pages (from-to) | 351-365 |
Number of pages | 15 |
Journal | Gastroenterology Clinics of North America |
Volume | 54 |
Issue number | 2 |
DOIs | |
State | Accepted/In press - 2025 |
Keywords
- Irritable bowel syndrome
- Metabolome
- Microbiome
- Postinfection irritable bowel syndrome
- Small intestinal bacterial overgrowth
ASJC Scopus subject areas
- Gastroenterology